drugset / Trial / NCT06775431
Comparing Prophylactic Intravenous Pethidine and Intrathecal Pethidine in Preventing Post Spinal Shivering in Caesarean Section
RandomizedParallel-groupSingle-blindPrevention
Summary
The goal of this clinical trial is to assess the effect of IV pethidine and intrathecal pethidine on the incidence, onset, duration, and intensity of shivering in females undergoing caesarean section. The main question it aims to answer is: which route is more efficacious in preventing shivering. Researchers will compare IV pethidine and intrathecal pethidine to see their effects on post spinal shivering, their effects on hemodynamic stability, nausea, vomiting, and sedation.
Timeline
- Start
- 2024-12-10
- Primary completion
- 2025-02
- Completion
- 2025-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Meperidine | Unknown | 0.2 mg/kg | Intravenous |
| Comparator | Meperidine | Unknown | 0.5 mg/kg | Intravenous |
Indications
No indication recorded.